World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
55047
World Ranking
5268
National Ranking
2843

David S. Alberts publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David S. Alberts sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 743 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David S. Alberts D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David S. Alberts sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David S. Alberts is affiliated with the University of Arizona in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Oncology, Surgery, Obstetrics and Gynecology, Reproductive Medicine, and Pulmonary and Respiratory Medicine.

Their work covers a range of topics including:

  • Ovarian cancer diagnosis and treatment
  • Cancer survivorship and care
  • Endometrial and Cervical Cancer Treatments
  • Intraperitoneal and Appendiceal Malignancies
  • Lymphatic System and Diseases
  • Systemic Sclerosis and Related Diseases
  • Colorectal and Anal Carcinomas

David S. Alberts has published in several scientific venues. The most frequent publication venues include:

  • Gynecologic Oncology
  • UNC Libraries
  • Journal of Clinical Oncology
  • Journal of Biomedical Optics
  • Colorectal Cancer

Examples of recent papers authored or coauthored by David S. Alberts include:

  • Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix, 2023, Journal of Clinical Oncology
  • GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function, 2020, Gynecologic Oncology
  • Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors, 2023, Gynecologic Oncology
  • Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes, 2021, Journal of Biomedical Optics
  • Characteristics and risk factors for early-onset metachronous colorectal adenoma, 2020, Colorectal Cancer

The scientist often collaborates with several coauthors, including:

  • Joan L. Walker
  • Linda Van Le
  • Paul DiSilvestro
  • Saketh R. Guntupalli
  • Michael Yozwiak

Best Publications

  • Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix

    William A. Peters;P.Y. Liu;Rolland J. Barrett;Richard J. Stock

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P.S.J. Meltzer;Y.D. Chen;Y. Jiang

  • Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.

    Janine G. Einspahr;David S. Alberts;Susan M. Gapstur;Roberd M. Bostick

  • Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

    David S. Alberts;P. Y. Liu;Edward V. Hannigan;Robert O'Toole

  • Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

    Maurie Markman;Brian N. Bundy;David S. Alberts;Jeffrey M. Fowler

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

    Sydney E. Salmon;Anne W. Hamburger;Barbara Soehnlen;Brian G. M. Durie

  • Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials

    Claire Vale;Jayne F. Tierney;Lesley A. Stewart;Mark Brady

  • Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

    George Pettit;S. B. Singh;E. Hamel;C. M. Lin

  • Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

    Michael A. Bookman;Mark F. Brady;William P. McGuire;Peter G. Harper

  • Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

    H-H. Sherry Chow;Yan Cai;Iman A. Hakim;James A. Crowell

  • Ovarian Cancer: Screening, Treatment, and Follow-up

    Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld

  • A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy

    María Elena Martínez;John A. Baron;David A. Lieberman;Arthur Schatzkin

  • MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer

    Lanlan Shen;Yutaka Kondo;Gary L. Rosner;Lianchun Xiao

  • Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial

    Maurie Markman;P.Y. Liu;Sharon Wilczynski;Bradley Monk

  • Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis

    Gary A. Piazza;Alanna L. Kulchak Rahm;Mary Krutzsch;Gerhard Sperl

  • Phase I Pharmacokinetic Study of Tea Polyphenols following Single-dose Administration of Epigallocatechin Gallate and Polyphenon E

    H-H. Sherry Chow;Yan Cai;David S. Alberts;Iman Hakim

  • Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

    Joyce A. O’Shaughnessy;Gary J. Kelloff;Gary B. Gordon;Andrew J. Dannenberg

  • Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals

    H-H. Sherry Chow;Iman A. Hakim;Donna R. Vining;James A. Crowell

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P. Meltzer;Y. Chen;Y. Jiang

Frequent Co-Authors

Frank L. Meyskens
Frank L. Meyskens University of California, Irvine
Sydney E. Salmon
Sydney E. Salmon University of Arizona
James R. Marshall
James R. Marshall Roswell Park Cancer Institute
Zigang Dong
Zigang Dong University of Minnesota
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Dennis J. Ahnen
Dennis J. Ahnen University of Colorado Denver
Ann M. Bode
Ann M. Bode University of Minnesota
Emanuel F. Petricoin
Emanuel F. Petricoin George Mason University
Thomas P. Davis
Thomas P. Davis University of Arizona
Anna R. Giuliano
Anna R. Giuliano University of South Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine but want flexible educational options, several online pathways can help you advance in the healthcare field. For those more interested in healthcare management than direct patient care, consider cahme accredited online healthcare administration programs. These programs are designed to give you the leadership skills needed for high-level roles in hospitals and clinics, often without the need to relocate or change your work schedule.

Registered nurses looking to further their education can pursue rn to bsn programs no clinicals, which allow RNs to earn advanced credentials 100% online, without additional in-person practicums.

For nurses aiming for the highest clinical degree, accelerated dnp programs online make it possible to fast-track a Doctor of Nursing Practice in as little as one year, depending on your background. Certain online dnp programs without clinicals can also be an option, offering advanced leadership and policy education without on-site requirements.

These online options support diverse medical and healthcare goals, maximizing flexibility for working professionals and students worldwide.

Best Scientists Citing David S. Alberts

Trending Scientists

Recently Published Articles